W
Werner Hacke
Researcher at Heidelberg University
Publications - 688
Citations - 93115
Werner Hacke is an academic researcher from Heidelberg University. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 123, co-authored 656 publications receiving 84593 citations. Previous affiliations of Werner Hacke include University Hospital Heidelberg & Steklov Mathematical Institute.
Papers
More filters
Journal ArticleDOI
MRI in acute subarachnoid haemorrhage; findings with a standardised stroke protocol
Jochen B. Fiebach,Peter D. Schellinger,Karsten Geletneky,P. Wilde,M. Meyer,Werner Hacke,Klaus Sartor +6 more
TL;DR: Stroke MRI within 6 h of symptom onset on five patients with minor subarachnoid haemorrhage (SAH) diagnosed by CT shows a characteristic pattern, and an aneurysm in only one patient.
Journal ArticleDOI
Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis
Brigitte Wildemann,K. Ehrhart,B. Storch-Hagenlocher,Uta Meyding-Lamadé,S Steinvorth,Werner Hacke,Juergen Haas +6 more
TL;DR: The absence of a clear correlation between viral load in the CSF and morbidity may suggest a role for indirect mechanisms of brain injury in HSVE.
Journal ArticleDOI
Cerebral Oxygen Transport Failure?: Decreasing Hemoglobin and Hematocrit Levels After Ischemic Stroke Predict Poor Outcome and Mortality STroke: RelevAnt Impact of hemoGlobin, Hematocrit and Transfusion (STRAIGHT)—an Observational Study
Lars Kellert,Evgenia Martin,Marek Sykora,Harald Bauer,Philipp Gussmann,Jennifer Diedler,Christian Herweh,Peter A. Ringleb,Werner Hacke,Thorsten Steiner,Julian Bösel +10 more
TL;DR: Poor outcome and mortality after ischemic stroke are strongly associated with low and further decreasing Hb and Hct levels, which might be more relevant and accessible to treatment than are baseline levels.
Journal ArticleDOI
Acute treatment of ischaemic stroke. European Stroke Initiative
TL;DR: Treatment of acute ischaemic stroke remains essential in order to improve outcome and to lower mortality, and there are 5 main areas in the treatment of acute stroke, including neuroprotection, prophylaxis and treatment of complications.
Journal ArticleDOI
State-of-the-Art Review: Anticoagulation: The Present and Future
Hugo Van Aken,Christoph Bode,Harald Darius,Curt Diehm,Albrecht Encke,Dietrich C. Gulba,Sylvia Haas,Werner Hacke,Wolfhart Puhl,Markus Quante,Hanno Riess,Rüdiger E. Scharf,Sebastian Schellong,Karsten Schrör,Karl-Ludwig Schulte,Ulrich Tebbe +15 more
TL;DR: The development of reversible noncovalent DTIs has resulted in safer, more specific and predictable anticoagulant treatment, and Oral DTIs, such as ximelagatran, are set to provide a further breakthrough in the prophylaxis and treatment of thrombosis.